Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs lidocaine intra-articular injection in knee osteoarthritis
ChiCTR2500106243Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in knee osteoarthritis (OA) and pain (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Incidence of treatment-emergent adverse events of special interest within 1 week post-intra-articular injection therapy. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
knee osteoarthritis (OA)pain
Beyond the preview
Go deeper on ChiCTR2500106243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106243.